Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients

Soborun, N.; Müller, M.; Abdurashidova, T.; Tzimas, G.; Schukraft, S.; Lu, H.; Hugli, O.; Vollenweider, P.; Garnier, A.; Monney, P.; Hullin, R. (2022). Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients. Biomedicine & pharmacotherapy, 154, p. 113615. Elsevier 10.1016/j.biopha.2022.113615

[img]
Preview
Text
1-s2.0-S0753332222010046-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (471kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center

UniBE Contributor:

Müller, Martin (B)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1950-6007

Publisher:

Elsevier

Language:

English

Submitter:

Romana Saredi

Date Deposited:

01 Nov 2022 13:02

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.1016/j.biopha.2022.113615

PubMed ID:

36057219

BORIS DOI:

10.48350/174394

URI:

https://boris.unibe.ch/id/eprint/174394

Actions (login required)

Edit item Edit item
Provide Feedback